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Abstract
Antigen presenting cells (APC) have the ability to present both extra-cellular and intra-cellular antigens via MHC class I
molecules to CD8
+ T cells. The cross presentation of extra-cellular antigens is reduced in mice with deficient Antigen Peptide
Transporter 1 (TAP1)-dependent MHC class I antigen presentation, and these mice are characterized by a diminished CD8
+ T
cell population. We have recently reported an increased activation of CD8
+ T cells in hypercholesterolemic Apoe
2/2 mice.
Therefore, this study included TAP1-deficient Apoe
2/2 mice (Apoe
2/2Tap1
2/2) to test the atherogenicity of CD8
+ T cells and
TAP1-dependent cross presentation in a hypercholesterolemic environment. As expected the CD8
+ T cell numbers were low
in Apoe
2/2Tap1
2/2 mice in comparison to Apoe
2/2 mice, constituting ,1% of the lymphocyte population. In spite of this
there were no differences in the extent of atherosclerosis as assessed by en face Oil Red O staining of the aorta and cross-
sections of the aortic root between Apoe
2/2Tap1
2/2 and Apoe
2/2 mice. Moreover, no differences were detected in lesion
infiltration of macrophages or CD3
+ T cells in Apoe
2/2Tap1
2/2 compared to Apoe
2/2 mice. The CD3
+CD4
+ T cell fraction
was increased in Apoe
2/2Tap1
2/2 mice, suggesting a compensation for the decreased CD8
+ T cell population. Interestingly,
the fraction of CD8
+ effector memory T cells was increased but this appeared to have little impact on the atherosclerosis
development. In conclusion, Apoe
2/2Tap1
2/2 mice develop atherosclerosis equal to Apoe
2/2 mice, indicating a minor role
for CD8
+ T cells and TAP1-dependent antigen presentation in the disease process.
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Introduction
According to the current view, oxidized LDL (oxLDL) within
the vascular wall initiates an immune response leading to influx of
phagocytes and T cells to the inflammatory site, which ultimately
leads to a chronic inflammation and growth of atherosclerotic
lesions [1,2]. Hypercholesterolemia promotes atherosclerosis and
leads to an imbalance in pro- and anti-atherogenic T cell
populations. Pro-atherogenic T cells specific for oxLDL are found
in atherosclerotic lesions and circulation [3,4] and mice deficient
in CD4
+ T cells displayed decreased lesion size [5,6]. In contrast,
Elhage et al. reported increased lesion development in cd4
2/2 mice
[7] whereas Dansky et al. stated that T and B cells had a minor
impact in atherosclerosis [8]. The balance between pro- and anti-
atherogenic signals within the T cell population may determine
disease development. The induction of regulatory CD4
+ T cells is
anti-atherogenic [9] while depletion leads to increased lesion
development [10], highlighting the dual role of CD4
+ T cells and
that imbalance may accelerate atherosclerosis. Less focus has been
on the role of CD8
+ T cells in atherosclerosis. Elhage et al. reported
that aortic lesions of Apoe
2/2 mice deficient in CD8
+ T cells
receiving chow diet did not differ in size compared to Apoe
2/2
mice with a normal CD8
+ T cell population [7]. In contrast CD8
+
T cells were found to comprise up to 50% of the lymphocyte
population in advanced human atherosclerotic lesions [11] and
Apoe
2/2 mice expressing b-galactosidase (b-gal) in aortic smooth
muscle cells (SMCs) developed CD8
+ T cell driven arteritis and
atherosclerosis upon immunization with b-gal specific dendritic
cells (DC) [12]. We recently conducted a study in hypercholes-
terolemic Apoe
2/2 mice comparing the CD4
+ and CD8
+ T cell
responses early in the disease process. There was an induction of
CD8
+IFN-c
+ cells in heart draining lymph nodes and spleen and
increased proliferation of CD8
+ splenocytes compared to CD4
+
counterparts [13]. This prompted us to formulate the hypothesis
that a hyperlipidemic diet leads to activation of effector CD8
+ T
cells that drive development of atherosclerotic plaques in a CD4
+-
independent way. To test this, Tap1
2/2 mice [14] were crossed
with Apoe
2/2 mice to generate a hypercholesterolemic mouse
model with low CD8
+ T cell numbers. The antigen peptide
transporter 1 (TAP1) together with TAP2 constitutes a MHC class
I transporter maintaining the major pathway of MHC class I
surface expression. TAP1 is important for thymic differentiation of
T cells and deficiency result in a diminished pool of peripheral
CD8
+ T cells [15]. Since CD8
+ T cells can get activated by extra-
cellular antigens presented via MHC class I cross presentation
[16], diminishing this pathway would possibly affect pro-
atherogenic CD8
+ T cell responses. Surprisingly, the Apoe
2/2
Tap1
2/2 mice developed lesions of the same size as the Apoe
2/2
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33932mice, indicating that TAP1-deficiency has no or minor effect on
atherosclerosis.
Materials and Methods
Ethics Statement
The Local Animal Care and Use Committee at Lund University
approved (Permit numbers M159-07 and M153-10) the experi-
mental protocol used in the study. All surgery was performed
under anesthesia, and all efforts were made to minimize suffering.
Animals
Female apolipoprotein E deficient- and TAP1-deficient mice on
a C57BL/6 background were purchased from Jackson Laborato-
ries, USA and C57BL/6 (wild type, WT) mice were obtained from
in house breeding. To generate double deficient mice, Apoe
2/2
and Tap1
2/2 mice were crossed to obtain parental genotypes. The
number of animals used was 10–13 and 7–10 per experimental
group for mice sacrificed at 26 and 14 weeks of age, respectively.
All animals were controlled for respective genetical background by
PCR assay. Tap1
2/2 and Apoe
2/2Tap1
2/2 mice did not have
detectable levels of Tap1. The animals were kept under controlled
laboratory conditions in individually ventilated cages (IVC) and
food and water were provided ad libitum. The Apoe
2/2Tap1
2/2
mice did not display any obvious phenotypically differences in
comparison to Apoe
2/2 mice such as body weight and blood lipids
(table 1 and 2). Further, we recorded no premature death or
abnormal behavior. Thus, they appeared healthy, but Tap1
2/2
mice had bald, non-fur covered areas in the back, which was not
apparent in Apoe
2/2Tap1
2/2, Apoe
2/2 or WT mice. At the age of
6 weeks, diet was shifted from chow to high fat diet (HFD; 0.15%
cholesterol and 21% fat (Lantma ¨nnen, Sweden)). The mice were
sacrificed at 8 or 20 weeks after diet change by intraperitoneal
injection of Xylazine (Rompun, Bayer Health care), and Ketamine
(Ketalar, Pfizer), in sodium chloride solution (0.9%) and
exsanguinated by cardiac puncture, perfused with 5 ml PBS
(pH 7.4), followed by removal of spleen and lymph nodes and
thereafter infusion of 5 ml of the fixative Histochoice (Amresco,
Solon, Ohio). The aorta was then dissected free of connective
tissue and fat, cut longitudinally, mounted en face and stored in
Histochoice. The heart was collected and stored in Histochoice at
4uC until processing. Plasma was collected from cardiac punction
and stored at 280uC until assayed. In a second set of experiments
female mice (6 Apoe
2/2 mice and 6 Apoe
2/2Tap1
2/2 mice) were
sacrificed 22 weeks after diet change. However, histochoice was
not used, lymphoid organs were not assayed and the heart was
snap frozen in liquid nitrogen and stored at 280uC.
Analysis of plaque macrophage, T cell and neutral lipid
content
The heart was embedded in OCT (Optimal Cutting Temper-
ature; Tissue-TekZoeterwoulde, The Netherlands) and frozen
sections of 10 mm were collected. All staining experiments were
done at room temperature if not stated otherwise. Macrophage
stained sections were fixed in ice-cold acetone for 10 minutes,
incubated with 0.5% Triton-6100 (Merck Chemicals, Darmstadt,
Germany) and 3% H2O2 (Apoteket AB, Sweden) for 5 minutes,
each step separated by PBS rinsing. Thereafter the sections were
blocked with 10% mouse serum in PBS for 30 minutes and quickly
dipped in PBS before staining with a rat anti-mouse MOMA-2
antibody (monocyte/macrophage, BMA Biomedicals, Augst,
Switzerland) diluted in 10% rat serum in PBS and incubated at
+4uC over night. The slides were incubated with biotinylated
rabbit anti-rat IgG (BA-4001, Vector Laboratories, Burlingame,
CA) for 50 minutes followed by a 30-minute incubation with ABC
solition (ABC elite, Vector Laboratories) and color development
using the DAB detection kit (Vector Laboratories). For T cell
detection, slides were fixed in acetone, washed and permeabilized
using Triton-6100 followed by incubation with H2O2 according
to the MOMA-2 protocol. Slides were incubated for 30 minutes in
10% goat serum followed by incubation with rabbit anti-human
CD3 (cross-reacts with mouse CD3 [17]; A0452, Dako Cytoma-
tion, Fort Collins, CO) diluted in 2% goat serum at 4uC overnight.
This was followed by a 50-minute incubation with biotinylated
goat anti-rabbit IgG (BA-1000, Vector Laboratories) and the
ABC/DAB procedure according to the MOMA-2 protocol.
Omissions of the primary or secondary antibodies were used as
negative controls. To analyze T cell subsets in aortic root lesions
sections of snap frozen heart tissue were fixed in acetone for
15 minutes, rehydrated in PBS for 10 minutes and incubated with
0.3% H2O2 for 2 minutes followed by PBS wash. The sections
were blocked with 10% mouse serum for 30 minutes followed by a
15 minute block with avidin (Thermo Scientific) and a 15 minute
block with biotin (Thermo Scientific). The slides were washed with
PBS and incubated with rat anti-mouse CD4 (553044, clone
RM4-5, BD Pharmingen) or rat anti-mouse CD8a (553029, clone
53-6.7, BD Pharmingen) diluted in 10% mouse serum for
30 minutes. Omission of the antibody was used as negative
Table 1. Lesion size, weight, plasma cholesterol and
triglycerides at 14 weeks of age.
WT Tap1
2/2 Apoe
2/2
Apoe
2/
2Tap1
2/2
Lesion size
(mm
2610
23)
n/a n/a 318.7693.9 350.16119.8
Weight (g) 25.564.4 20.661.4
a 22.962.4 21.361.9
Cholesterol (mg/dl) 86.8626.8 71.9615.3 604.6687.3
b 650.0692.7
b
Triglycerides (mg/dl)25.7615.7 24.767.1 42.665.4
c 50.067.9
d
n/a, not applicable;
aP,0.01 vs. WT,
bP,0.001 vs. WT and Tap1
2/2,
cP,0.01 vs. Tap1
2/2,
dP,0.001 vs. WT and Tap1
2/2. The number of animals in respective group was
7 (WT), 10 (Tap1
2/2), 10 (Apoe
2/2)a n d7( Apoe
2/2Tap1
2/2). In the triglyceride
assay, one Apoe
2/2Tap1
2/2 mouse displayed 3 times higher values than group
mean and was excluded from analysis.
doi:10.1371/journal.pone.0033932.t001
Table 2. Plasma cholesterol, triglycerides and weight at 26
weeks of age.
WT Tap1
2/2 Apoe
2/2 Apoe
2/2Tap1
2/2
Cholesterol 104.3621.0 85.1611.6 792.66101.3
a,b 740.16134.6
a,b
Triglycerides 24.5618.8 33.8623.8 47.6617.7
c 54.0620.1
d,e
Weight 33.566.6
f 22.263.6 24.463.1 22.561.6
aP,0.01 vs. WT,
bP,0.001 vs. Tap1
2/2,
cP,0.01 vs. WT,
dP,0.001 vs. WT,
eP,0.05 vs. Tap1
2/2,
fP,0.001 vs. Tap1
2/2, Apoe
2/2 and Apoe
2/2Tap1
2/2. The number of animals in
respective group was 12 (WT), 13 (Tap1
2/2), 11 (Apoe
2/2)a n d1 3( Apoe
2/2
Tap1
2/2).
doi:10.1371/journal.pone.0033932.t002
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MOMA-2 protocol. For lipid staining, the sections were put in
0.24% Oil red O diluted in 60% isopropanol for 10 minutes,
rinsed with tap water to remove redundant Oil red O, and dipped
in 60% isopropanol followed by washing with dH2O before
nuclear staining with hematoxylin for 15 seconds. En face
preparations of the aorta were washed in distilled water, dipped
in 78% methanol, and stained for 40 minutes in 0.16% Oil red O
dissolved in 78% methanol/0.2 mol/L NaOH as previously
described [18]. The cover slides were mounted with a water
soluble mounting media L-550A (Histolab, Go ¨teborg, Sweden).
Oil red O stains lipids red, which makes the plaques bordeaux
colored. Stained area and total lesion area of all immunohisto-
chemical and histochemical analyses were quantified by micros-
copy and computer aided morphometry by a blinded observer
(BioPix IQ 2.0, Go ¨teborg, Sweden).
Cell preparation and flow cytometry
A. Mice analyzed at 26 weeks of age. The spleen and
mediastinal lymph nodes (MeLN) were meshed through a cell
strainer (70 mm, BD Bioscience). The single cell suspension of the
lymph nodes were washed in RPMI medium (Gibco, USA) and
resuspended in complete medium (RPMI 1640 supplemented with
10% FCS, 1% Sodium pyruvate, 1% Hepes, 1% Penicillin/
Streptomycin, 1% L-Glutamine and 0.1% b mercaptoethanol
[Gibco]). Splenocytes were pelleted and resuspended in red blood
cell lyzing buffer (Sigma) for two minutes at room temperature to
remove erythrocytes. Cells were washed and resuspended in
complete medium. Spleen and MeLN cells were distributed in 96-
well round bottom plates (Sarstedt, Landskrona, Sweden) at a
density of 1.5610
6 cells/ml for antibody staining.
Cells were then
divided into groups being antibody stained directly (day 0) or after
ConcanavallinA (ConA) incubation (day 2). Directly stained cells
were incubated with a Fc-receptor blocking antibody (FcR;CD16/
32; clone 93, Biolegend) for 5 minutes followed by incubation with
either of two antibody panels. For panel one; CD80-PE (clone 16-
10A1), CD11c-PE/Cy7 (N4-18), CD86-PB (GL-1) and I-A/I-E-
A700 (M5-114.15.2) (all Biolegend, San Diego, CA, USA except
CD80-PE; eBioscience, San Diego, CA, USA) and panel two
CD44-AF488 (IM7), CD122-PE (5H4), CD3-PE/Cy7 (145-2C11),
CD4-PB (GK1.5), CD62L-APC (MEL-14) and CD8-APC/Cy7
(53-6.7) at 4uC for 30 minutes. 7AAD (Sigma; 1 ml/sample) was
included in both panels. Further, cells were washed with FC buffer
(0.5% bovine serum albumin (Sigma) and 0.5 mM EDTA in
phosphate buffered saline) and incubated with 4% PFA
(paraformaldehyde; Sigma) for 20 minutes followed by wash and
resuspension in FC buffer. Cells in the day 2-group were first
incubated in presence or absence of 0.625 mg/ml ConA (Sigma)
and incubated for 2 days at 37uC and 5% CO2. The antibody
staining procedure was identical to the procedure for the day 0-
group and both groups were acquired in the same flow cytometry
run. Measurements were performed using a Cyan ADP (Beckman
Coulter, Brea, CA, USA), analyses were performed using FlowJo
(Treestar inc., Ashland, OR, USA, version 7.6.1) and gating was
adjusted using fluorescence minus one (FMO) control staining.
B. Mice analyzed at 14 weeks of age. The MeLN were
meshed through a cell strainer (70 mm, BD Bioscience). The single
cell suspension of the lymph nodes was washed in cell medium
(PBS (Gibco), 2% FCS, 2 mM EDTA) and resuspended in RPMI-
1640 (Gibco). The spleens were minced into pieces and incubated
in spleen dissociation buffer (Stemcell Technologies, Vancouver,
Canada) according to manufacturer’s instructions. Cells were
resuspended in RPMI-1640 and distributed in 96-well round
bottom plates (Sarstedt) at a density of 1610
6 cells/ml. Thereafter
cells were incubated with a Fc-receptor blocking antibody
(FcR;CD16/32; clone 93, Biolegend) for 5 minutes followed by
incubation with CD3-PE/Cy7 (145-2C11), CD4-PB (GK1.5) and
CD25-APC (PC61; all Biolegend) for 30 minutes at 4uC. The cells
were resuspended in Fix/Perm solution (eBioscience), washed with
permeabilization buffer (eBioscience) and blocked with FcR for
5 minutes prior to incubation with FoxP3-PE (MF-14, Biolegend)
for 30 minutes at 4uC. Cells were washed with permeabilization
buffer, resuspended in FC buffer (1% fetal calf serum (Gibco) and
0.5 mM EDTA in PBS) and acquired as described for the 26
weeks old mice.
Proliferation of splenocytes from mice at 14 weeks of age
Spleen CD11c
+ cells were isolated using Easy sep CD11c
+
positive selection kit (Stemcell Technologies) with a purity of 71%.
Subsequently CD4
+ cells were isolated using Easy sep CD4c
+
positive selection kit (Stemcell Technologies) with a purity of 70%
followed by CD8
+ cell isolation using Easy sep mouse CD8
+ T cell
enrichment kit (Stemcell Technologies) with a purity of 89%.
CD11c
+, CD4
+ and CD8
+ cells (each 5610
4/well) were cultured
in medium (RPMI-1640 medium containing 10% heat-inactivated
fetal calf serum, 1 mmol/L sodium pyruvate, 10 mmol/L Hepes,
50 U penicillin, 50 mg/mL streptomycin, 0.05 mmol/L b-mer-
captoethanol and 2 mmol/L L-glutamine, Gibco, Invitrogen) in
96-well round bottom plates (Sarstedt) in presence or absence of
0.625 mg/ml ConA (Sigma) for 72 hours at 37uC and 5% CO2.
To measure cell proliferation, [methyl-
3H] thymidine (Perkin-
Elmer, Waltham, MA, USA) was added (20 ml/well diluted 1:20)
and incubated 16–20 hours. Macromolecular material was then
harvested on glass fiber filters using a Printed Filtermat A (1450-
421, Wallac Oy, Turku, Finland). Filters were air-dried and the
bound radioactivity was measured in a beta-counter (Wallac 1450
MicroBeta, Ramsey, MN, USA).
Analysis of cytokines in plasma
Cytokine concentrations in plasma were analyzed using a mouse
Th1/Th2 9-Plex (IFN-c, IL-1b, TNF-a, IL-2, IL-12, IL-4, IL-5,
IL-10 and KC/GRO/CINC (CXCL1) Ultra-Sensitive Kit (Meso
Scale Discovery, Gaithersburg, MO, USA), following the
instructions of the manufacturer. Samples were analyzed sepa-
rately for each individual animal. The lower detection limit in this
assay was 1.02–9.50 pg/ml depending on the cytokine assayed.
Analysis of cholesterol and triglyceride content
Total plasma cholesterol and plasma triglycerides were
quantified with colorimetric assays, Infinity
TM Cholesterol and
Triglyceride (Thermo Electron, Waltham, MA, USA).
Statistical analysis
Analysis of data was performed using unpaired t test or Mann
Whitney test for skewed data. Data are presented as mean6-
standard deviation. Kruskal-Wallis test and Dunn’s post hoc test
was used to analyze plasma triglyceride data. Analysis was
performed using GraphPad Prism 5.01 (Graphpad software, La
Jolla, CA, USA) and a level of P,0.05 was considered significant.
Results
Characterization of the mouse model and quantification
of atherosclerosis
We first quantified CD8
+ T cells in Apoe
2/2 mice and
counterparts deficient in the MHC class I transporter TAP1. As
expected the CD8
+ T cell fraction and numbers were low in
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+ T cells in spleen and mediastinal lymph nodes (MeLN). Flow cytometry graphs showing the cell populations in spleen from
one representative mouse from each group (A). Numbers given in the graphs are per cent cells out of all lymphocytes. The fraction (B) and total cell
count (C) of CD8
+ T cells in spleen and MeLN of Apoe
2/2, Apoe
2/2 Tap1
2/2 and Tap1
2/2 mice. The cells were isolated from respective tissue, stained
with fluorescent antibodies and analyzed by flow cytometry. As expected, the CD8
+ T cell fraction was depressed in the mice lacking the Tap1 gene.
Each dot in the figure represents one mouse. ***P,0.001.
doi:10.1371/journal.pone.0033932.g001
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2/2Tap1
2/2 and Tap1
2/2 mice in comparison to Apoe
2/2
mice, constituting ,1% of the lymphocyte population (figure 1A–
C). However, after 20 weeks of high fat diet the Apoe
2/2Tap1
2/2
mice had equal lesion size compared to Apoe
2/2 mice in aortic
root (figure 2A and 2B), aorta (figure 2C) and greater- respective
lesser curvature of the aortic arch (data not shown). WT and
Tap1
2/2 mice did not develop quantifiable lesions and were
excluded from analysis. The same pattern was found in mice given
high fat diet for 8 weeks (table 1). Since TAP1 deficiency could
influence inflammation and lipid accumulation in the lesions we
analyzed the T cell-, macrophage- and lipid content in the old
mice as indicators of lesion stability. No differences were detected
in lesion infiltration of macrophages (20.865.8% vs. 21.363.8%)
or CD3
+ T cells (30.7610.2% vs. 25.663.6%) in Apoe
2/2Tap1
2/2
compared to Apoe
2/2 mice. There were no detectable amounts of
CD8
+ T cells in lesions of mice given HFD for 22 weeks (data not
shown). Further, no differences were found in CD4
+ T cell lesion
infiltration in Apoe
2/2Tap1
2/2 compared to Apoe
2/2 mice (data
not shown). The neutral lipid accumulation in the lesions was not
affected(11.264.5%inApoe
2/2Tap1
2/2vs.13.864.3%inApoe
2/2).
Thus, TAP1 deficiency does not induce severe alterations in the intra-
lesional milieu. Systemically, plasma cholesterol and triglyceride
levels were not different between groups on Apoe
2/2 background but
as expected levels were increased in these groups compared to mice
on an Apoe
+/+ background (table 1 and 2). The weights did not differ
between Apoe
2/2 and Apoe
2/2Tap1
2/2 mice (table 1 and 2).
Cell characterization
The T cell and dendritic cell (DC) populations of spleen and
MeLN were analyzed to characterize the response to hypercho-
lesterolemia systemically and in conjunction to lesions. While
viable CD3
+ T cells were less abundant in spleen of Apoe
2/2
Tap1
2/2 mice (figure 3A and 3B), there was no difference in
MeLN compared to Apoe
2/2 mice (figure 3B). The fraction of
CD3
+CD4
+ T cells was higher in Apoe
2/2Tap1
2/2 mice and
Tap1
2/2 mice compared to Apoe
2/2mice in both spleen and
MeLN (figure 3A and 3C and data not shown). While the increase
in spleen was moderate, the CD3
+CD4
+ T cell compartment in
MeLN was almost doubled (figure 3C), which may explain the
difference in CD3
+ T cells between the groups in spleen compared
to the indifference between groups in MeLN (figure 3B). However,
since the number of CD4
+ T cells did not differ in MeLN
(figure 3D) the relative rise in the CD4
+ T cell population is likely a
result of the diminished CD8
+ T cell population. Interestingly, the
numberofCD4
+TcellsinspleenincreasedintheApoe
2/2Tap1
2/2
mice (figure 3D). Since this population could mediate inflammation
we analyzed the fraction of memory effector cells. There was no
difference in CD4
+CD44
+CD62L
2 T cells in Apoe
2/2Tap1
2/2
mice compared to Apoe
2/2mice in MeLN or spleen (figure S1A).
Surprisingly, the corresponding CD8
+ population was approxi-
mately eight times larger in MeLN and spleen of Apoe
2/2Tap1
2/2
mice compared to Apoe
2/2mice (figure S1B). However, the
CD8
+CD44
+CD62L
+CD122
+ regulatory T cell [19] population
in the small CD8
+ T cell population was also higher in Apoe
2/2
Tap1
2/2 mice (figure S2), which could compensate rise in effector
cells. In contrast, within the CD4
+ population the
CD4
+CD25
+FoxP3
+ regulatory T cell fraction was decreased in
MeLN but not in spleen of Apoe
2/2Tap1
2/2 mice given HFD for 8
weeks (14 weeks old at death) compared to equivalent Apoe
2/2 mice
(figure S3). Since the major activation pathway of CD8
+ T cells
occur via DCs we analyzed abundance and activation of CD11c
+
cells in spleen and MeLN of 26 weeks old mice. The fraction of
CD11c
+ cells in spleen, but not in MeLN, was lower in Apoe
2/2
Tap1
2/2 mice compared to Apoe
2/2mice (figure 4B). Further,
Figure 2. Plaque area in aortic root and aorta. (A) Representative
images of plaques in the aortic root from one mouse in each group.
Quantification of plaque area in the aortic root (B) and aorta (C) of
Apoe
2/2 and Apoe
2/2Tap1
2/2 mice fed high fat diet for 20 weeks. The
tissues were stained with Oil red O (ORO) and analyzed by a blinded
observer. Each dot in the figure represents one mouse.
doi:10.1371/journal.pone.0033932.g002
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+ cells in both organs expressed lower levels of CD80, CD86
and a trend towards decreased MHC class II levels (figure 4A, 4C
and 4D).
Cell characterization of proliferated lymphoid cells
In order to elucidate the proliferative response of CD4
+ and
CD8
+ T cells, lymphocyte suspensions from spleen and MeLN
were incubated with ConA for two days. The fraction of respective
cell type was assessed at day 0 and day 2 using flow cytometry
analyses. The cell pattern at day 0 is presented in figure 1 and 3.
However, incubation with ConA resulted in a robust rise in
CD3
+CD8
+ T cells at day 2 in the Apoe
2/2Tap1
2/2 mice in both
spleen and MeLN (figure S4). Interestingly, the CD3
+CD8
+ T cell
population at day 2 was also increased in Apoe
2/2mice in
comparison to CD3
+CD4
+ T cells (figure S4). This may indicate
that the CD3
+CD8
+ T cells respond strongly to the ConA
incubation while the CD3
+CD4
+ T cells are weak responders.
Proliferation of splenocytes
To test the impact of antigen presenting cells (APCs) on the
proliferation of separated CD4
+ and CD8
+ T cells we performed
analysis in mice given high fat diet for 8 weeks (14 weeks old at
death). The CD4
+ and CD8
+ T cells from Apoe
2/2Tap1
2/2 mice
and Apoe2/2 mice were magnetically separated and stimulated
for three days with ConA and an equal amount of CD11c
+ cells.
In this setting the CD8
+ T cells proliferate poorly in both Apoe
2/2
Tap1
2/2 mice and Apoe2/2 mice (figure 5). In contrast, CD4
+ T
cells proliferate more than the CD8
+ T cells in both groups.
Interestingly, CD4
+ T cells had an increased proliferation in
Apoe
2/2Tap1
2/2 mice compared to Apoe
2/2 mice (figure 5).
Stimulation of T cells with ConA is considered to give an
estimation of the T cell priming status from the in vivo
environment. Thus, cells in the CD4
+ co-culture seems to be
more pre-primed compared to cells in the CD8
+ co-culture and
more in TAP deficient animals.
Plasma cytokines
The plasma level of IL-12, IL-1b, KC, IFN-c, TNF-a, IL-2, IL-
10, IL-4 and IL-5 was analyzed but no differences between the
groups of mice were found (data not shown).
Discussion
T cell immunity plays an important role in the development of
atherosclerosis, but the participation of CD8
+ T cells and MHC
class I antigen presentation has not been fully investigated.
Previous reports on the role of CD8
+ T cells in the development of
atherosclerosis are few and describe a diverse impact on disease
indicating a need for further characterization. We recently
evaluated the CD8
+ T cell response to hypercholesterolemia in
an Apoe
2/2 mouse model leading to the conclusion that initial
atherosclerosis is characterized by a CD8
+ T cell response which
was more rapid and stronger than the corresponding CD4
+ T cell
response [13]. The hypothesis of the current study was therefore
Figure 3. CD3
+ T cells and CD4
+ T cells in spleen and MeLN. Flow
cytometry graphs showing the cell populations in spleen from one
representative mouse from each group (A). Numbers given in the
graphs are per cent cells out of all lymphocytes. The fraction of CD3
+ T
cells (B), CD3
+CD4
+ T cells (C) and CD3
+CD4
+ T cell numbers (D) in
Apoe
2/2 and Apoe
2/2 Tap1
2/2 mice in spleen and MeLN. The cells were
isolated from respective tissue, stained with fluorescent antibodies and
analyzed by flow cytometry. Each dot in the figure represents one
mouse. *P,0.05, ***P,0.001.
doi:10.1371/journal.pone.0033932.g003
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2/2 mouse model with few CD8
+ T cells (Apoe
2/2
Tap1
2/2) would have a decreased lesion development in response
to a high fat diet compared to an Apoe
2/2 mouse model with
normal levels of CD8
+ T cells. However, lesion size was found to
be equal in the Apoe
2/2Tap1
2/2 mice and Apoe
2/2 mice. As lesion
size in younger mice display the same pattern, the lesion severity
may be of less importance in this system. However, as the diet
composition may impact the presence of antigens implicated in
autoimmune lymphocyte response, experimental groups given
chow diet could have been included in the study. Interestingly, a
study in which chow-fed Apoe
2/2 mice with a mutation in the
CD8-encoding gene Lyt-2 developed equivalent atherosclerosis as
Apoe
2/2 mice with functional CD8
+ T cells [7]. Accordingly,
neither loss of function in CD8
+ T cells nor the TAP1-dependent
CD8
+ T cell activation is essentially affecting the lesion
development. The result raises the question if 1) the CD4
+ T
cell population compensate pro-inflammatory effects of the normal
CD8
+ T cell population or 2) the CD8
+ T cell population is not
involved in the disease process. The CD4
+ fraction of Tap1
2/2
and Apoe
2/2Tap1
2/2 mice was enlarged compared to TAP1-
expressing mice in contrast to studies in Tap1
2/2 mice [14] and
Tap1
2/2 humans [20] having normal CD4
+ levels. Although the
effector memory CD4
+ T cell population was equal in both
groups, the actual number of cells was larger in Apoe
2/2Tap1
2/2
mice due to the enlarged CD4
+ T cell population. Moreover, the
CD4
+CD25
+FoxP3
+ regulatory T cell population was decreased in
MeLN of the group given HFD for 8 weeks supporting a disease-
driving property of this T cell subset. Hence, pro-atherogenic cells
within this population may maintain disease by compensating for
the loss of CD8
+ T cells. Apart from this, diminishment of the
CD8
+ T cell population may reduce the impact of both pro- and
anti-inflammatory CD8
+ T cells on atherosclerosis. This could be
a transient process or affect either of the cell populations more
than the other. Interestingly, incubation of lymphocytes with
ConA resulted in an increased fraction of CD8
+ T cells while the
CD4
+ T cells were weak responders and displayed a decrease in
the fraction of lymphocytes. This supports the data presented in
our previous study [13] and results by Aldrich et al. describing a
strong antigen-specific response in CD8
+ T cells from Tap1
2/2
mice [21]. However, when splenic CD4
+ or CD8
+ T cells were
mixed with CD11c
+ cells and stimulated with the polyclonal T cell
activator ConA, there was an increased proliferation in CD4
+
cultures from Apoe
2/2Tap1
2/2 mice compared to corresponding
CD8
+ cultures. Furthermore, the CD4
+ cultures from Apoe
2/2
Tap1
2/2 mice proliferated more than corresponding cultures in
Apoe
2/2 mice. Since CD8
+ T cells benefit from CD4
+ T cell
assistance [22] the proliferation of the isolated CD8
+ T cells may
benegativelyregulated.Incontrast,theCD4
+T cellsintheApoe
2/2
Tap1
2/2 mice seem to be more pre-primed than in the Apoe2/2
mice. Taken together, the data may indicate that CD8
+ T cells need
CD4
+ T cell help to proliferate properly and CD4
+ T cell
proliferation may be inhibited by CD8
+ T cell proliferation in a
co-culture. Since the results of this in vitro testing seem to have little
impact on the disease mechanism it may not be reflected in vivo.T h e
in vivo system may promote other functional mechanisms and/or the
CD8
+ T cells may not respond to endogenous antigens present in
the in vivo system as strong as they respond to ConA. Thus, the
CD8
+ T cell population in Apoe
2/2Tap1
2/2 mice was only 12% of
that in Apoe
2/2 mice but it contained relatively more effector
memory- and regulatory T cells. Although CD8
+ T cells in TAP1-
deficient mice are known to be functional [23], the effector cell- and
regulatory T cell population here was still smaller than in Apoe
2/2
mice, giving them a limited impact on atherosclerosis.
Since about one third of all MHC class I-peptide complexes are
presented via the TAP1-independent pathway [24] it was expected
that abundance as well as activation of CD11c
+ DCs would be
lower in Apoe
2/2Tap1
2/2 mice than Apoe
2/2 mice as was
demonstrated in the present study. Considering the size of the
CD8
+ T cell population the remaining CD11c
+ cell population
may be sufficient to increase the CD8
+ effector memory cell
population. Consequently, the larger CD4
+ T cell population may
not be adequately stimulated to achieve a similar rise in effector
memory cells. However, activation of CD4
+ and CD8
+ T cells
involve not only APC derived MHC class I/II-TCR contact but
also stimulation from CD4
+ T cells. They can acquire MHC class
I/II-peptide complexes from APCs and together with co-
stimulatory molecules activate CD4
+ or CD8
+ T cells and increase
the APC derived stimulation [22]. Thus, the decreased DC
activation in Apoe
2/2Tap1
2/2 mice may be compensated by
antigen presentation mediated by the increased CD4
+ T cell
population, potentially activating both pro-inflammatory CD4
+
and CD8
+ T cell subsets. However, activation of CD4
+ and/or
CD8
+ T cell subsets targeting antigens present in atherosclerotic
lesions would result in increased lesional T cell infiltration. As the
Figure 4. CD11c
+ cells and expression of CD80
+, CD86
+ and MHC class II
+ on CD11c
+ cells in spleen and MeLN. Histograms
corresponding to the cell populations in the spleen from one representative mouse from each group (A). Gate boundaries were set by fluorescence
minus one controls (solid grey). The fraction of CD11c
+ cells (B) and CD11c
+CD80
+, CD11c
+CD86
+ and CD11c
+MHCII
+ cells in spleen (C) and MeLN (D)
of Apoe
2/2 and Apoe
2/2 Tap1
2/2 mice. The cells were isolated from respective tissue, stained with fluorescent antibodies and analyzed by flow
cytometry. Each dot in the figure represents one mouse. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0033932.g004
Figure 5. Proliferation of splenic CD4
+ and CD8
+ co-cultures of
young mice. Proliferation were analysed in ConA stimulated (90 hrs)
CD4
+:CD11c
+ (CD4
+) and CD8
+:CD11c
+ (CD8
+) cell co-cultures in Apoe
2/
2 and Apoe
2/2Tap1
2/2 mice with presence of radioactive labelled
thymidine during the last 16–20 hrs. The cells were isolated from
spleens of mice given high fat diet for 8 weeks and magnetically
separated into CD11c
+, CD4
+ and CD8
+ cells. CPM denotes counts per
minute. Each dot in the figure represents one mouse. *P,0.05.
doi:10.1371/journal.pone.0033932.g005
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impact of T cells for lesion development may be questioned in this
model. Moreover, the macrophage lesion infiltration was not
affected indicating that TAP1 deficiency does not exert major
APC-driven effects on atherosclerosis progression. Thus, the
similar lesion size in Apoe
2/2 mice and Apoe
2/2Tap1
2/2 mice
reflects a minor role of TAP1 for atherosclerosis development.
However, the mice of this study were housed in an environment
with low exposure to infections. Several pathogens, including
Chlamydia pneumoniae, herpes simplex virus and cytomegalovirus
have been associated with atherosclerosis [25]. As CD8
+ T cells
are activated by bacterial/viral antigens via TAP dependent- and
independent pathways [16] it is conceivable that the model of this
study contains limitations. Thus, assuming a low infectious burden
in the mice of the present study, a reduced amount of autoreactive
CD8
+ T cells targeting lesion specific antigens may favor other
atherogenic cell types.
In conclusion, hypercholesterolemic Apoe
2/2 mice that lack
TAP1-dependent antigen presentation develop atherosclerotic
lesions, inflammatory cell infiltration and lipid accumulation equal
to Apoe
2/2 mice. The relative CD4
+ T cell population was larger
in both local and systemic lymphoid tissues in Apoe
2/2Tap1
2/2
mice compared to Apoe
2/2 mice, whereas CD4
+ T cell numbers
were increased in spleen but not in MeLN. In addition, the
CD11c
+ population had a lower expression of activation markers
in Apoe
2/2Tap1
2/2 mice. Although the effector memory T cell
population was larger in the small CD8
+ T cell population of
Apoe
2/2Tap1
2/2 mice the impact on disease is likely to be limited.
Taken together, the present study provides novel information
indicating a limited role of TAP1 and CD8
+ T cells in
atherosclerosis development.
Supporting Information
Figure S1 Effector memory CD4
+ T cells and CD8
+ T
cells in spleen and MeLN. The fraction of (A)
CD3
+CD4
+CD44
+CD62L
2 and (B) CD3
+CD8
+ CD44
+CD62L
2
T cells in spleen and MeLN of Apoe
2/2 and Apoe
2/2 Tap1
2/2
mice. The cells were isolated from respective tissue, stained with
fluorescent antibodies and analyzed by flow cytometry. Each dot
in the figure represents one mouse. ***P,0.001.
(TIF)
Figure S2 Regulatory CD8
+ T cells in spleen and MeLN.
Analysis of CD3
+CD8
+CD44
+CD62L
+ CD122
+ T cells in Apoe
2/2
and Apoe
2/2 Tap1
2/2 mice in spleen and MeLN. The cells were
isolated from respective tissue, stained with fluorescent antibodies
and analyzed by flow cytometry. Each dot in the figure represents
one mouse. ** P,0.01, ***P,0.001.
(TIF)
Figure S3 Regulatory CD4
+ T cells in spleen and MeLN
of young mice. Analysis of CD3
+ CD4
+CD25
+FoxP3
+ T cells in
spleen and MeLN of Apoe
2/2 and Apoe
2/2 Tap1
2/2 mice given
HFD for 8 weeks. The cells were isolated from respective tissue,
stained with fluorescent antibodies and analyzed by flow
cytometry. Each dot in the figure represents one mouse.
**P,0.01.
(TIF)
Figure S4 ConA-stimulation of lymphocytes. Lympho-
cytes from spleen and MeLN were incubated with ConA for 2 days
and the relative fraction of CD4
+ and CD8
+ T cells was assessed
by flow cytometry analysis. The CD8
+ T cell fraction was larger
than the CD4
+ T cell fraction in spleen and MeLN of both Apoe
2/2
and Apoe
2/2 Tap1
2/2 mice. ** P,0.01, ***P,0.001.
(TIF)
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